Personalized pathways
“We are moving to a more precise, proactive, and personalized model of healthcare, and diagnostics are the lens that make that precision possible.”
William Morice II, M.D., Ph.D., president and CEO, Mayo Clinic Laboratories
The latest
Specialized immunofluorescence testing helps uncover rare autoimmune blistering diseases, identify underlying cancers, and guide precise treatment, improving diagnostic accuracy and outcomes for patients with challenging skin disorders.
Learn five ways to accelerate diagnostic innovation while safeguarding patient trust, data integrity, and regulatory readiness.
Christopher Garcia, M.D., chief digital innovation officer at Mayo Clinic Laboratories, shares how laboratories can use AI to expand access to data, personalize care, and transform the future of diagnostics.
Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic Laboratories' innovative business approach. As a platform company, Mayo Clinic is creating a diagnostics ecosystem to meet a wide range of testing needs and help physicians order the right tests for their patients.
Advanced diagnostics play a critical role in guiding personalized care for patients with rare diseases. Isabel’s journey demonstrates how specialized laboratory testing delivers diagnostic clarity and supports individualized care decisions. Watch her story to learn more about the impact of Mayo Clinic Laboratories.

Precision care starts with accurate answers